Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

SLNSLN
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in Silence Therapeutics PLC Sponsored ADR

GOLDMAN SACHS GROUP INC holds 155,929 shares of SLN (Silence Therapeutics PLC Sponsored ADR), worth $1.7M as of 2026-Q2. The position was increased (+196.9% shares). SLN represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$1.7M

Current Shares

155,929

Total Value Change

+$1.5M

Total Shares Change

+119,044

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
155,929
+196.9%
$1.7M0.0%$10.98
41
2026-Q1
Increased
52,511
+189.9%
$276,7330.0%$5.66
26
2025-Q4
Decreased
18,114
-20.0%
$110,1330.0%$6.15
0
2025-Q3
New
22,644
-
$117,5220.0%$5.67
34
2025-Q2
Exited
0
-100.0%
$00.0%$5.79
0
2025-Q1
Decreased
24,375
-33.9%
$68,7380.0%$3.44
0
2024-Q4
New
36,885
-
$253,7690.0%$6.91
35

Other major holders of SLN: MILLENNIUM MANAGEMENT LLC, Janus Henderson Group Ltd., Polar Capital Holdings Plc

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used